Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Boosts Pandemic Flu Vaccine Stockpile With Contracts Totaling $200 Mil.

This article was originally published in The Pink Sheet Daily

Executive Summary

Sanofi Pasteur, Novartis and GlaxoSmithKline stand to benefit from government's goal of adding 5.3 mil. doses to national stockpile.

You may also be interested in...



FDA Licenses First H5N1 Vaccine From Sanofi Pasteur

Avian influenza vaccine will not be commercially available but will be included in the national stockpile, FDA says.

FDA Licenses First H5N1 Vaccine From Sanofi Pasteur

Avian influenza vaccine will not be commercially available but will be included in the national stockpile, FDA says.

Clinical Development Of Bird Flu Vaccines For Pre-Pandemic Uses To Be Discussed By Cmte.

FDA’s Vaccines and Related Biological Products Advisory Committee will meet Feb. 27.

Related Content

Topics

UsernamePublicRestriction

Register

ID007083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel